All United asks public to support MG patient, caregiver rights’ petition
All United for MG has opened a petition in Europe supporting myasthenia gravis (MG) patient and caregiver rights, including…
Articles by Patricia Inacio, PhD
Low-dose course of rituximab effective for MuSK-MG: Small study
A treatment course of low-dose rituximab eased measures of clinical severity, improved quality of life, and allowed lower steroid…
IVIgs, immunosuppressants add up to higher MG healthcare costs in US
Myasthenia gravis (MG) patients on long-term treatment with intravenous immunoglobulin (IVIg) or nonsteroidal immunosuppressants have significantly higher rates…
Vyvgart safe, effective in hard-to-treat gMG, real-world study finds
Vyvgart (efgartigimod) generally is safe and leads to both significant symptom reductions and improvements in function in people with…
MuSK-MG more common in women in Japan, and often difficult to treat
Myasthenia gravis (MG) caused by the presence of self-reactive antibodies targeting muscle-specific kinase (MuSK) affects mostly women in Japan,…
MG and its symptoms seen as harder on women, seronegative patients
Among people with myasthenia gravis (MG) living in Australia, women and seronegative patients — those whose tests fail to…
Retroviral agents for HIV may have caused MG in woman: Case report
A 44-year-old woman positive for the human immunodeficiency virus (HIV) developed myasthenia gravis (MG) after receiving treatment with antiretroviral…
More physician and patient education needed on MG: Survey
More than half of myasthenia gravis (MG) patients take more than a year to be diagnosed from symptom onset…
Vyvgart approved to treat adults with gMG in China
Vyvgart (efgartigimod alfa) has been approved in China as an add-on to standard therapy for adults with generalized myasthenia gravis…
Noninvasive breathing test may detect declining respiratory function
The single breath count test (SBCT), a noninvasive and inexpensive pulmonary function test, may help evaluate respiratory function and identify…